Friend or foe: A novel role of β-defensins in tumor development

Area of Science:

• Immunology
• Cancer Biology
• Molecular Biology

Background:

• Beta-defensins (β-defensins) are primarily known for their antimicrobial properties.
• Emerging evidence suggests β-defensins possess immunomodulatory functions, including immune cell recruitment.
• Chemokine receptors mediate the chemotactic activity of β-defensins.

Purpose of the Study:

• To investigate the role of mouse β-defensin 14 (mBD14) in tumor development.
• To determine if mBD14 influences immune cell infiltration into tumors.
• To elucidate the specific immune cells and mechanisms involved in mBD14-mediated tumor effects.

Main Methods:

• Utilized a fibrosarcoma tumor model in mice.
• Administered mBD14 to assess its effects on tumor growth and angiogenesis.
• Analyzed immune cell populations within tumors using flow cytometry and immunohistochemistry.
• Investigated the role of chemokine receptor CCR6 in mBD14-induced cell recruitment.

Main Results:

• Mouse β-defensin 14 was found to recruit B cells expressing the chemokine receptor CCR6 into fibrosarcomas.
• This recruitment of B cells led to increased tumor angiogenesis (formation of new blood vessels).
• Enhanced angiogenesis correlated with accelerated tumor growth.

Conclusions:

• Mouse β-defensin 14 plays a significant role in tumor progression beyond its antimicrobial activity.
• mBD14 promotes tumor development by recruiting specific immune cells (CCR6+ B cells) that enhance angiogenesis.
• These findings reveal a novel mechanism by which β-defensins contribute to the tumor microenvironment and cancer growth.